Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial

医学 超声乳化术 白内障手术 视力 临床终点 外科 散光 围手术期 临床试验 随机对照试验 眼科 验光服务 光学 物理 病理
作者
Cédric Schweitzer,Antoine P. Brézin,Béatrice Cochener,Dominique Monnet,Christine Germain,Stéphanie Roseng,Rémi Sitta,Aline Maillard,Nathalie Hayes,Philippe Denis,P.J. Pisella,Antoine Bénard,Cati Albou-Ganem,Jean-Louis Arné,Emilie Bardet,Antoine Bénard,Catherine Bourreau,Antoine P. Brézin,Olivier Chatoux,C. Cochard,Béatrice Cochener,Joseph Colin,Philippe Denis,Vincent Fortoul,J. Galet,Florence Galliot,Georges Nicolas,Christine Germain,Anne Gimbert,Margaux Guillard,Thomas Habay,Nathalie Hayes,Laurent Kodjikian,Aline Maillard,Emilie Mercé,Dominique Monnet,Minh Nguyen,Romain Nicolau,Laurent Piazza,P.J. Pisella,J Rateau,Sophie Regueme,Stéphanie Roseng,Jean-Jacques Sarragoussi,Cédric Schweitzer,Rémi Sitta,David Touboul,Guillaume Vandenmeer
出处
期刊:The Lancet [Elsevier BV]
卷期号:395 (10219): 212-224 被引量:93
标识
DOI:10.1016/s0140-6736(19)32481-x
摘要

Background Cataract surgery is one of the most common operations in health care. Femtosecond laser-assisted cataract surgery (FLACS) enables more precise ocular incisions and lens fragmentation than does phacoemulsification cataract surgery (PCS). We hypothesised that FLACS might improve outcomes in cataract surgery compared with PCS despite having higher costs. Methods We did a participant-masked randomised superiority clinical trial comparing FLACS and PCS in two parallel groups (permuted block randomisation stratified on centres via a centralised web-based application, allocation ratio 1:1, block size of 2 or 4 for unilateral cases and 2 or 6 for bilateral cases). Five French University Hospitals enrolled consecutive patients aged 22 years or older who were eligible for unilateral or bilateral cataract surgery. Participants, outcome assessors, and technicians carrying out examinations were masked to the surgical treatment allocation until the last follow-up visit and a sham laser procedure was set up for participants randomly assigned to the PCS arm. The primary clinical endpoint was the success rate of surgery, defined as a composite of four outcomes at a 3-month postoperative visit: absence of severe perioperative complication, a best-corrected visual acuity (BCVA) of 0·0 LogMAR (logarithm of the minimum angle of resolution) or better, an absolute refractive error of 0·75 dioptres or less, and unchanged postoperative corneal astigmatism power (≤0·5 dioptres) and axis (≤20°). The primary economic endpoint was the incremental cost per additional patient who had treatment success at 3 months. Primary outcomes were assessed in all randomly assigned patients who met all eligibility criteria (missing data considered as failure). We used mixed logistic regression models or mixed linear regression models for statistical comparisons, adjusted on centres and whether cataract surgery was bilateral or unilateral. The study is registered with ClinicalTrials.gov, NCT01982006. Findings Of the 907 patients (1476 eyes) randomly assigned between Oct 9, 2013, and Oct 30, 2015, 870 (704 eyes in FLACS group and 685 eyes in the PCS group) were analysed. We identified no significant difference in the success rate of surgery between the FLACS and PCS groups (FLACS: 41·1% [289 eyes]; PCS: 43·6% [299 eyes]); adjusted odds ratio 0·85, 95% CI 0·64–1·12, p=0·250). The incremental cost-effectiveness ratio was €10 703 saved per additional patient who had treatment success with PCS compared with FLACS. We observed no severe adverse events during the femtosecond laser procedure, and most of the complications in the FLACS group related to the primary outcome measures occurred during the phacoemulsification phase or postoperatively. Interpretation Despite its advanced technology, femtosecond laser was not superior to phacoemulsification in cataract surgery and, with higher costs, did not provide an additional benefit over phacoemulsification for patients or health-care systems. Funding French Ministry of Social Affairs and Health.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1+1应助科研通管家采纳,获得10
1秒前
领导范儿应助科研通管家采纳,获得30
1秒前
pluto应助科研通管家采纳,获得10
2秒前
科目三应助科研通管家采纳,获得10
2秒前
1+1应助科研通管家采纳,获得10
2秒前
完美世界应助科研通管家采纳,获得20
2秒前
2秒前
胡萝卜应助科研通管家采纳,获得20
2秒前
岁末完成签到 ,获得积分10
2秒前
HEIKU应助科研通管家采纳,获得10
2秒前
科研通AI5应助科研通管家采纳,获得10
2秒前
科研通AI2S应助科研通管家采纳,获得10
2秒前
1+1应助科研通管家采纳,获得10
3秒前
爱笑的耳机完成签到,获得积分10
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
土木搬砖法律完成签到,获得积分10
3秒前
Owen应助科研通管家采纳,获得10
3秒前
Hello应助科研通管家采纳,获得10
3秒前
浅斟低唱发布了新的文献求助150
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
3秒前
1+1应助科研通管家采纳,获得10
3秒前
Singularity应助科研通管家采纳,获得10
3秒前
Singularity应助科研通管家采纳,获得10
3秒前
隐形曼青应助科研通管家采纳,获得10
4秒前
sanyecai完成签到,获得积分10
4秒前
小蘑菇应助科研通管家采纳,获得10
4秒前
淡定访琴完成签到,获得积分10
4秒前
HEIKU应助科研通管家采纳,获得10
4秒前
SCINEXUS应助科研通管家采纳,获得100
4秒前
思源应助科研通管家采纳,获得10
4秒前
JamesPei应助科研通管家采纳,获得10
4秒前
HarryYang完成签到 ,获得积分10
4秒前
科研通AI5应助科研通管家采纳,获得10
4秒前
HEIKU应助科研通管家采纳,获得10
4秒前
1+1应助科研通管家采纳,获得10
4秒前
5秒前
科研通AI5应助科研通管家采纳,获得10
5秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The First Nuclear Era: The Life and Times of a Technological Fixer 500
Unusual formation of 4-diazo-3-nitriminopyrazoles upon acid nitration of pyrazolo[3,4-d][1,2,3]triazoles 500
岡本唐貴自伝的回想画集 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3671625
求助须知:如何正确求助?哪些是违规求助? 3228325
关于积分的说明 9779625
捐赠科研通 2938636
什么是DOI,文献DOI怎么找? 1610180
邀请新用户注册赠送积分活动 760547
科研通“疑难数据库(出版商)”最低求助积分说明 736093